Alx Oncology Holdings Inc. Insider Trading

ALXO

⊜ Compare

Last 12 months

Insiders bought $5M and sold 43K on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan.

Net open-market

+$4.96M

1 buy · 7 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

1 / 2

executives and directors

Last open-market buy

Feb 2026

Feb 2, 2026

Get an email when ALXO's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Aug 17	Jason Lettmann Chief Executive Officer	SoldNo plan	2,230	$1.93	4K	0.8%	Form 4
Aug 17	Shelly Wong SVP, Finance and CAO	SoldNo plan	573	$1.93	1K	0.6%	Form 4
Jul 1	Shelly Wong SVP, Finance and CAO	SoldNo plan	1,404	$2.04	3K	1.6%	Form 4
Mar 19	Jason Lettmann Chief Executive Officer	SoldNo plan	12,311	$2.17	27K	4.0%	Form 4
Mar 19	Shelly Pinto SVP, Finance and CAO	SoldNo plan	903	$2.17	2K	1.0%	Form 4
Feb 18	Shelly Pinto SVP, Finance and CAO	SoldNo plan	565	$2.27	1K	0.6%	Form 4
Feb 2	Corey S Goodman Director	Bought	3,184,713	$1.57	$5M	60%	Form 4
Jan 6	Shelly Pinto SVP, Finance and CAO	SoldNo plan	3,925	$1.11	4K	4.3%	Form 4
Sep 16, 2025 – Sep 17, 2025	Jason Lettmann Chief Executive Officer	Bought 2 parts	92,233	$1.08 average	99K	43%	Form 4
Aug 18, 2025	Harish Shantharam Chief Financial Officer	Bought	75,000	$0.78	59K	New	Form 4
Aug 15, 2025	Shelly Pinto SVP, Finance and CAO	SoldNo plan	611	$0.64	$391	0.7%	Form 4
Aug 15, 2025	Jason Lettmann Chief Executive Officer	SoldNo plan	2,382	$0.64	2K	1.1%	Form 4
Jul 7, 2025	Shelly Pinto SVP, Finance and CAO	SoldNo plan	2,011	$0.45	$905	2.3%	Form 4
Jun 30, 2025	Shelly Pinto SVP, Finance and CAO	SoldNo plan	1,532	$0.43	$659	1.7%	Form 4
Feb 19, 2025	Shelly Pinto SVP, Finance and CAO	SoldNo plan	550	$1.15	$633	0.6%	Form 4
Feb 19, 2025	Jaume Pons President & Cso	SoldNo plan	1,326	$1.15	2K	0.2%	Form 4
Feb 19, 2025	Jason Lettmann Chief Executive Officer	SoldNo plan	2,159	$1.15	2K	1.3%	Form 4
Jan 6, 2025	Shelly Pinto Interim CFO	SoldNo plan	2,221	$1.80	4K	2.5%	Form 4
Dec 30, 2024	Shelly Pinto Interim CFO	SoldNo plan	1,426	$1.58	2K	1.6%	Form 4
Dec 30, 2024	Jaume Pons President & Cso	SoldNo plan	10,796	$1.58	17K	1.8%	Form 4
Dec 2, 2024	Rekha Hemrajani Director	Bought	30,000	$1.55	47K	1000%	Form 4

Aug 17No plan
Jason Lettmann
Chief Executive Officer · sold 2,230 at $1.93
4K
0.8% of stake
Aug 17No plan
Shelly Wong
SVP, Finance and CAO · sold 573 at $1.93
1K
0.6% of stake
Jul 1No plan
Shelly Wong
SVP, Finance and CAO · sold 1,404 at $2.04
3K
1.6% of stake
Mar 19No plan
Jason Lettmann
Chief Executive Officer · sold 12,311 at $2.17
27K
4.0% of stake
Mar 19No plan
Shelly Pinto
SVP, Finance and CAO · sold 903 at $2.17
2K
1.0% of stake
Feb 18No plan
Shelly Pinto
SVP, Finance and CAO · sold 565 at $2.27
1K
0.6% of stake
Feb 2
Corey S Goodman
Director · bought 3,184,713 at $1.57
$5M
60% of stake
Jan 6No plan
Shelly Pinto
SVP, Finance and CAO · sold 3,925 at $1.11
4K
4.3% of stake
Sep 16, 2025 – Sep 17, 2025
Jason Lettmann
Chief Executive Officer · bought 92,233 at avg $1.08
99K
43% of stake
Aug 18, 2025
Harish Shantharam
Chief Financial Officer · bought 75,000 at $0.78
59K
New position
Aug 15, 2025No plan
Shelly Pinto
SVP, Finance and CAO · sold 611 at $0.64
$391
0.7% of stake
Aug 15, 2025No plan
Jason Lettmann
Chief Executive Officer · sold 2,382 at $0.64
2K
1.1% of stake
Jul 7, 2025No plan
Shelly Pinto
SVP, Finance and CAO · sold 2,011 at $0.45
$905
2.3% of stake
Jun 30, 2025No plan
Shelly Pinto
SVP, Finance and CAO · sold 1,532 at $0.43
$659
1.7% of stake
Feb 19, 2025No plan
Shelly Pinto
SVP, Finance and CAO · sold 550 at $1.15
$633
0.6% of stake
Feb 19, 2025No plan
Jaume Pons
President & Cso · sold 1,326 at $1.15
2K
0.2% of stake
Feb 19, 2025No plan
Jason Lettmann
Chief Executive Officer · sold 2,159 at $1.15
2K
1.3% of stake
Jan 6, 2025No plan
Shelly Pinto
Interim CFO · sold 2,221 at $1.80
4K
2.5% of stake
Dec 30, 2024No plan
Shelly Pinto
Interim CFO · sold 1,426 at $1.58
2K
1.6% of stake
Dec 30, 2024No plan
Jaume Pons
President & Cso · sold 10,796 at $1.58
17K
1.8% of stake
Dec 2, 2024
Rekha Hemrajani
Director · bought 30,000 at $1.55
47K
1000% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch ALXO, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with ALXO

CompareIntrinsic value

LGVNLongeveron Inc.

$1.67-4.57%10

NEUPNeuphoria Therapeutics Inc.

$3.05-0.33%10

SXTP60 Degrees Pharmaceuticals Inc.

$0.94-0.84%40

IGCIGC Pharma Inc.

$0.19-5.00%26

ORGSOrgenesis Inc.

$0.05+0.00%20

TERNTerns Pharmaceuticals, Inc.

$0.01+0.00%10

STTKShattuck Labs Inc.

$5.56-2.80%40

DAREDare Bioscience Inc.

$0.69+1.89%10

Held by ETFs

ALXO is in 3 US ETFs. The largest of them, with ALXO's weight in each:

Spot a number that looks wrong? Check it in ALXO's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ALXO

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.